These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17917847)

  • 1. We have a problem: why have ALS trials been negative?
    Swash M
    Amyotroph Lateral Scler; 2007 Oct; 8(5):259. PubMed ID: 17917847
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroprotective agents for clinical trials in ALS: systematic assessment.
    Burke WJ
    Neurology; 2007 Feb; 68(9):709; author reply 710. PubMed ID: 17325287
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: What is next in ALS clinical trials?
    Hoke A
    Neurology; 2008 Apr; 70(16):1366; author reply 1366-7. PubMed ID: 18413595
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective agents for clinical trials in ALS: a systematic assessment.
    Traynor BJ; Bruijn L; Conwit R; Beal F; O'Neill G; Fagan SC; Cudkowicz ME
    Neurology; 2006 Jul; 67(1):20-7. PubMed ID: 16832072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
    Leigh PN; Swash M; Iwasaki Y; Ludolph A; Meininger V; Miller RG; Mitsumoto H; Shaw P; Tashiro K; Van Den Berg L
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):84-98. PubMed ID: 15204010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database.
    Miller RG; Anderson F; Brooks BR; Mitsumoto H; Bradley WG; Ringel SP;
    Ann Neurol; 2009 Jan; 65 Suppl 1():S24-8. PubMed ID: 19191307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining survival as an outcome measure in amyotrophic lateral sclerosis.
    Gordon PH; Corcia P; Lacomblez L; Pochigaeva K; Abitbol JL; Cudkowicz M; Leigh PN; Meininger V
    Arch Neurol; 2009 Jun; 66(6):758-61. PubMed ID: 19506136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Learning from failed trials in ALS.
    Swash M
    Lancet Neurol; 2007 Dec; 6(12):1034-5. PubMed ID: 17980666
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials in ALS: measurement and natural history.
    Munsat TL; Hollander D; Andres P; Finison L
    Adv Neurol; 1991; 56():515-9. PubMed ID: 1853780
    [No Abstract]   [Full Text] [Related]  

  • 12. Designing clinical trials in amyotrophic lateral sclerosis.
    Shefner JM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):495-508, ix. PubMed ID: 18625412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summing up: An action plan for ALS research.
    Rowland LP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():141-3. PubMed ID: 15512899
    [No Abstract]   [Full Text] [Related]  

  • 14. Zeroing in on Amyotrophic lateral sclerosis. A look at a new era of ALS research.
    Health After 50 Sci Am Consum Health; 2015 Dec; 27(12):4-5. PubMed ID: 26685335
    [No Abstract]   [Full Text] [Related]  

  • 15. ALSFRS-R.
    Gordon PH; Miller RG; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():90-3. PubMed ID: 15512883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combined Assessment of Function and Survival (CAFS): a new endpoint for ALS clinical trials.
    Berry JD; Miller R; Moore DH; Cudkowicz ME; van den Berg LH; Kerr DA; Dong Y; Ingersoll EW; Archibald D
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Apr; 14(3):162-8. PubMed ID: 23323713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALS trial design: expectation and reality.
    Miller RG; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():52-4. PubMed ID: 15512873
    [No Abstract]   [Full Text] [Related]  

  • 18. ALS endpoints. Survival.
    Cedarbaum J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():79-83. PubMed ID: 15512880
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventilation in ALS.
    de Carvalho M; Pinto A
    Amyotroph Lateral Scler; 2006 Mar; 7(1):3-4. PubMed ID: 16546752
    [No Abstract]   [Full Text] [Related]  

  • 20. What is next in ALS clinical trials?
    Sorenson EJ
    Neurology; 2007 Aug; 69(8):719-20. PubMed ID: 17709702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.